
Liteprazole 40mg Injection
Marketer
Unilight Pharma
Salt Composition
Pantoprazole (40mg)
Overview Liteprazole 40mg Injection
Intravenous Liteprazole 40mg is a medication that diminishes gastric acid production. Its applications encompass the management of acid-related gastrointestinal disorders including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, offering both symptomatic relief and tissue repair. This injectable formulation also prevents stress ulcers in critically ill patients and is prophylactically administered pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), it's administered intravenously by a healthcare provider only when deemed clinically preferable to oral administration. Dosage and treatment duration are determined by your physician based on individual needs and response. Optimal treatment may be enhanced by adopting a diet of smaller, more frequent meals, and minimizing consumption of caffeinated beverages, spicy foods, and fatty foods. Commonly reported adverse effects are nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While usually mild, persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year, may increase the risk of bone fractures, especially at higher doses; discuss bone health preservation strategies, such as calcium and vitamin D supplementation, with your doctor. This medication is contraindicated in individuals with severe hepatic impairment, those concurrently using HIV medications, those with a history of PPI allergy, and those with pre-existing osteoporosis. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol should be avoided due to its acid-stimulating properties. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Primary Ingredients of Liteprazole 40mg Injection
No text provided to rephrase.
Uses of Liteprazole 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Liteprazole 40mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Liteprazole 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Liteprazole 40mg Injection:
The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Liteprazole 40mg Injection works:
Stomach acid is neutralized by the proton pump inhibitor Liteprazole 40mg Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Combining Liteprazole 40mg Injection and alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The use of Liteprazole 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of 40mg Liteprazole Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Liteprazole 40mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Liteprazole 40mg Injection is considered safe and requires no dosage modification.
LiverCAUTION
For patients with severe hepatic impairment, the administration of 40mg Liteprazole Injection requires careful consideration and potential dosage modification. Physician consultation is recommended.
What if you forget to take Liteprazole 40mg Injection :
Should you forget a scheduled dose of the 40mg Liteprazole injection, seek advice from your physician.
Facts to Know About Liteprazole 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | PPIs |
